Wyse, PhD, Jessica J., Benjamin J. Morasco, PhD, Steven K. Dobscha, MD, Michael I. Demidenko, BS, Thomas H. A. Meath, MPH, and Travis I. Lovejoy, PhD, MPH. 2018. “Provider Reasons for Discontinuing Long-Term Opioid Therapy Following Aberrant Urine Drug Tests Differ Based on the Type of Substance Identified”. Journal of Opioid Management 14 (4):295-303. https://doi.org/10.5055/jom.2018.0461.